Yes- RDs and Pharmacists are essential in managing these side effects, given GI side effects are the primary reason people discontinue in year one
Danish pharma major Novo Nordisk (NOV: N) late Thursday announced that the US Food and Drug Administration (FDA) has approved Wegovy HD (once-weekly injectable semaglutide 7.2mg) to reduce excess body weight and maintain weight reduction long-term
The latter route has a large advantage of adding circulation time to the drug, allowing long-lasting effects of the drugs, potentially reducing the administration frequency and possibly also lowering gastrointestinal complications, as currently only subcutaneous and very few oral routes have been explored
Although several type 2 diabetes treatments are available, therapy selection involves consideration of the risks of adverse effects such as hypoglycemia (low blood sugar) or weight gain and complexity of treatment
Jesper Lau, Paw Bloch, and Thomas Kruse Hansen are listed as inventors
We are proud to offer pure, potent, and quality products that consumers can count on, which is why we have every product batch third-party tested